Evidence map›Paper›PMID 36569838›Full record

ArticleFrontiers in immunology2022

Longitudinal serum proteomics analyses identify unique and overlapping host response pathways in Lyme disease and West Nile virus infection.

Patrick Boada, Benoit Fatou, Alexia A Belperron, Tara K Sigdel, Kinga K Smolen, Zainab Wurie, Ofer Levy, Shannon E Ronca, Kristy O Murray, Juliane M Liberto and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Insights From Omics in Lyme Disease.The Journal of infectious diseases · 2024
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Patrick BoadaDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
Benoit FatouDepartment of Pathology, Boston Children's Hospital - Harvard Medical School, Boston, MA, United States.
Alexia A BelperronDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Tara K SigdelDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
Kinga K SmolenPrecision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.
Zainab WurieDepartment of Pathology, Boston Children's Hospital - Harvard Medical School, Boston, MA, United States.
Ofer LevyPrecision Vaccines Program, Boston Children's Hospital, Boston, MA, United States.
Shannon E RoncaDivision of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Kristy O MurrayDivision of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Juliane M LibertoDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
Priyanka RashmiDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
Maggie KerwinDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
Ruth R MontgomeryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Linda K BockenstedtDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
Hanno SteenDepartment of Pathology, Boston Children's Hospital - Harvard Medical School, Boston, MA, United States.
Minnie M SarwalDivision of Transplant Surgery, Department of Surgery, University of California, San Francisco, CA, United States.
University of California, San Francisco · USHarvard University · USYale University · USBaylor College of Medicine · USBoston Children's Hospital · USBroad Institute · USTexas Children's Hospital · US

Funding

Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7M
Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LANIER, LEWIS LEE · 2017 to 2021
$11.2M
Renal And Neurological Outcomes In Chronically Infected West Nile Virus PatientsR01AI091816 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, KRISTY · 2011 to 2014
$1.5M
NIAID NIH HHS R01 AI091816NIAID NIH HHS U19 AI089992NIAID NIH HHS U19 AI118608NIAID NIH HHS U19 AI128913
6 · The paper itself

Abstract

Advancement in proteomics methods for interrogating biological samples has helped identify disease biomarkers for early diagnostics and unravel underlying molecular mechanisms of disease. Herein, we examined the serum proteomes of 23 study participants presenting with one of two common arthropod-borne infections: Lyme disease (LD), an extracellular bacterial infection or West Nile virus infection (WNV), an intracellular viral infection. The LC/MS based serum proteomes of samples collected at the time of diagnosis and during convalescence were assessed using a depletion-based high-throughput shotgun proteomics (dHSP) pipeline as well as a non-depleting blotting-based low-throughput platform (MStern). The LC/MS integrated analyses identified host proteome responses in the acute and recovery phases shared by LD and WNV infections, as well as differentially abundant proteins that were unique to each infection. Notably, we also detected proteins that distinguished localized from disseminated LD and asymptomatic from symptomatic WNV infection. The proteins detected in both diseases with the dHSP pipeline identified unique and overlapping proteins detected with the non-depleting MStern platform, supporting the utility of both detection methods. Machine learning confirmed the use of the serum proteome to distinguish the infection from healthy control sera but could not develop discriminatory models between LD and WNV at current sample numbers. Our study is the first to compare the serum proteomes in two arthropod-borne infections and highlights the similarities in host responses even though the pathogens and the vectors themselves are different.

Indexed as

Lyme DiseaseWest Nile FeverWest Nile virusHumansProteomeProteomicsProteomeacute-phase responseasymptomatic infectionimmune systemlocalized and disseminated stagelongitudinal analysisLyme diseaseserum proteomicsWest Nile virus

Identifiers

PMID36569838
PMCPMC9784464
OpenAlexW4312010840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.